Trademark & Affiliation Disclaimer
Independent Site Notice: This is an independent, unaffiliated review website. We are NOT affiliated, endorsed, sponsored, or connected in any way with Nexaph. All trademarks belong to their respective owners. This site only provides user-submitted public information and third-party reviews for educational reference.
References to “Nexaph” on this website are nominative fair use: identifying the subject of public discussion, consumer research and community sentiment. We do not use or display vendor logos, product photographs, or proprietary brand assets. No content on this site should be read as authorization, endorsement or partnership of any kind.
Medical Disclaimer
Medical Disclaimer: All content on this website is compiled from public user discussions for informational purposes only. This is NOT medical advice. Peptides and GLP-1 agonists are prescription compounds. Do not start, adjust or stop any treatment without consulting a licensed healthcare provider. We do not endorse any peptide vendor or medical treatment.
Peptides and GLP-1 receptor agonists - including retatrutide, tirzepatide and semaglutide - are prescription medicines or investigational compounds in most jurisdictions. Content on this site that references clinical trials describes published findings under medical supervision; it is not a prediction of any outcome from any product, sourced or unsourced. If you have a medical concern, including after using any compound obtained outside licensed channels, consult a qualified healthcare provider.
Content Sourcing & Anecdote Labeling
Community-reported experiences summarized on this site are anecdote. They are user-submitted or publicly posted accounts of unknown reliability, not clinical observations, and they cannot authenticate what any product contains. Where we summarize them, we do so to describe the shape of public discussion, not to assert facts about any vendor or product.
The anecdote-labeling rule is not caution for its own sake - it reflects how unreliable unlabeled user content has become. In 2024 the U.S. Federal Trade Commission finalized a rule banning fake or AI-generated consumer reviews, precisely because fabricated testimonials had become a standard commerce tool; the grey market this site covers predates and will outlast that rule, operating largely outside its reach. Against that backdrop, the only honest default is to treat every anonymous testimonial as unverifiable until proven otherwise, and our review-literacy guide teaches the checks that separate genuine reports from manufactured ones.
Regulatory Status Reference
Because our coverage discusses compounds with sharply different regulatory standings, the reference table below is the stable backdrop for every compound mention on this site:
| Compound | US (FDA) | UK (MHRA) | EU (EMA) | Lawful retail without prescription? |
|---|---|---|---|---|
| Semaglutide | Approved (Wegovy, Ozempic) | Approved, POM | Approved | No |
| Tirzepatide | Approved (Zepbound, Mounjaro) | Approved, POM | Approved | No |
| Liraglutide | Approved (Saxenda) | Approved, POM | Approved | No |
| Retatrutide | Investigational - not approved | Investigational | Investigational | No legal channel exists |
Practical consequences of that table appear throughout coverage: for approved compounds, unlicensed sale is unlawful because they are regulated prescription medicines; for retatrutide, no lawful consumer channel exists at all. Nothing in our coverage should be read as guidance toward any channel other than licensed medical supply.
Advertising Parameters, in Detail
The reserved ad slots on this site operate under fixed parameters, stated here in full: advertisements are served identically to every visitor with no user-agent or referrer differentiation (this site implements no cloaking of any kind); they are visually labeled; they carry rel="nofollow sponsored" on any outbound link; they play no role in editorial coverage, and no vendor can pay for coverage, placement within coverage, or removal of coverage. Advertising, if present, is the site’s only revenue - which keeps the incentive visible rather than hidden in affiliate links. We do not accept advertising from sellers of unlicensed pharmaceuticals.
Why state these parameters publicly? Because the incentive structure of a review site is itself a content claim. A page recommending (or damning) a vendor while quietly earning a commission on the resulting orders is an advertisement wearing editorial clothes. Publishing our constraints is the cheapest way to let readers check them - the ads are visible, the disclaimers are on every page, and the methodology is documented rather than implied.
Advertising Disclosure
This site reserves advertising slots. Any advertisements displayed are served identically to all visitors and are clearly labeled. Advertising is not endorsed editorially, does not constitute vendor recommendations, and plays no role in what we cover or how. We do not accept payment for reviews, coverage, placement or suppression of coverage from any vendor.
External Links
Links to third-party websites are provided for reference only. We are not responsible for third-party content, availability, accuracy or practices. A link is not an endorsement.
Corrections
Public discussion evolves, and coverage based on it must evolve too. If you believe content on this site is outdated, incomplete or wrong, contact us via the Contact & Corrections page. Substantive corrections are made promptly and, where material, noted on the affected page.